Safi U Khan1, Muhammad U Khan1, Haris Riaz2, Shahul Valavoor1, Di Zhao3, Lauren Vaughan4, Victor Okunrintemi4, Irbaz Bin Riaz5, Muhammad Shahzeb Khan6, Edo Kaluski7, M Hassan Murad5, Michael J Blaha8, Eliseo Guallar9, Erin D Michos10. 1. West Virginia University, Morgantown, West Virginia (S.U.K., M.U.K., S.V.). 2. Cleveland Clinic, Cleveland, Ohio (H.R.). 3. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (D.Z.). 4. East Carolina University, Greenville, North Carolina (L.V., V.O.). 5. Mayo Clinic, Rochester, Minnesota (I.B.R., M.H.M.). 6. John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois (M.S.K.). 7. Guthrie Robert Packer Hospital, Sayre, Pennsylvania (E.K.). 8. Johns Hopkins School of Medicine, Baltimore, Maryland (M.J.B.). 9. Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, Baltimore, Maryland (E.G.). 10. Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (E.D.M.).
Abstract
Background: The role of nutritional supplements and dietary interventions in preventing mortality and cardiovascular disease (CVD) outcomes is unclear. Purpose: To examine evidence about the effects of nutritional supplements and dietary interventions on mortality and cardiovascular outcomes in adults. Data Sources: PubMed, CINAHL, and the Cochrane Library from inception until March 2019; ClinicalTrials.gov (10 March 2019); journal Web sites; and reference lists. Study Selection: English-language, randomized controlled trials (RCTs) and meta-analyses of RCTs that assessed the effects of nutritional supplements or dietary interventions on all-cause mortality or cardiovascular outcomes, such as death, myocardial infarction, stroke, and coronary heart disease. Data Extraction: Two independent investigators abstracted data, assessed the quality of evidence, and rated the certainty of evidence. Data Synthesis: Nine systematic reviews and 4 new RCTs were selected that encompassed a total of 277 trials, 24 interventions, and 992 129 participants. A total of 105 meta-analyses were generated. There was moderate-certainty evidence that reduced salt intake decreased the risk for all-cause mortality in normotensive participants (risk ratio [RR], 0.90 [95% CI, 0.85 to 0.95]) and cardiovascular mortality in hypertensive participants (RR, 0.67 [CI, 0.46 to 0.99]). Low-certainty evidence showed that omega-3 long-chain polyunsaturated fatty acid (LC-PUFA) was associated with reduced risk for myocardial infarction (RR, 0.92 [CI, 0.85 to 0.99]) and coronary heart disease (RR, 0.93 [CI, 0.89 to 0.98]). Folic acid was associated with lower risk for stroke (RR, 0.80 [CI, 0.67 to 0.96]; low certainty), whereas calcium plus vitamin D increased the risk for stroke (RR, 1.17 [CI, 1.05 to 1.30]; moderate certainty). Other nutritional supplements, such as vitamin B6, vitamin A, multivitamins, antioxidants, and iron and dietary interventions, such as reduced fat intake, had no significant effect on mortality or cardiovascular disease outcomes (very low- to moderate-certainty evidence). Limitations: Suboptimal quality and certainty of evidence. Conclusion: Reduced salt intake, omega-3 LC-PUFA use, and folate supplementation could reduce risk for some cardiovascular outcomes in adults. Combined calcium plus vitamin D might increase risk for stroke. Primary Funding Source: None.
Background: The role of nutritional supplements and dietary interventions in preventing mortality and cardiovascular disease (CVD) outcomes is unclear. Purpose: To examine evidence about the effects of nutritional supplements and dietary interventions on mortality and cardiovascular outcomes in adults. Data Sources: PubMed, CINAHL, and the Cochrane Library from inception until March 2019; ClinicalTrials.gov (10 March 2019); journal Web sites; and reference lists. Study Selection: English-language, randomized controlled trials (RCTs) and meta-analyses of RCTs that assessed the effects of nutritional supplements or dietary interventions on all-cause mortality or cardiovascular outcomes, such as death, myocardial infarction, stroke, and coronary heart disease. Data Extraction: Two independent investigators abstracted data, assessed the quality of evidence, and rated the certainty of evidence. Data Synthesis: Nine systematic reviews and 4 new RCTs were selected that encompassed a total of 277 trials, 24 interventions, and 992 129 participants. A total of 105 meta-analyses were generated. There was moderate-certainty evidence that reduced salt intake decreased the risk for all-cause mortality in normotensive participants (risk ratio [RR], 0.90 [95% CI, 0.85 to 0.95]) and cardiovascular mortality in hypertensiveparticipants (RR, 0.67 [CI, 0.46 to 0.99]). Low-certainty evidence showed that omega-3 long-chain polyunsaturated fatty acid (LC-PUFA) was associated with reduced risk for myocardial infarction (RR, 0.92 [CI, 0.85 to 0.99]) and coronary heart disease (RR, 0.93 [CI, 0.89 to 0.98]). Folic acid was associated with lower risk for stroke (RR, 0.80 [CI, 0.67 to 0.96]; low certainty), whereas calcium plus vitamin D increased the risk for stroke (RR, 1.17 [CI, 1.05 to 1.30]; moderate certainty). Other nutritional supplements, such as vitamin B6, vitamin A, multivitamins, antioxidants, and iron and dietary interventions, such as reduced fat intake, had no significant effect on mortality or cardiovascular disease outcomes (very low- to moderate-certainty evidence). Limitations: Suboptimal quality and certainty of evidence. Conclusion: Reduced salt intake, omega-3 LC-PUFA use, and folate supplementation could reduce risk for some cardiovascular outcomes in adults. Combined calcium plus vitamin D might increase risk for stroke. Primary Funding Source: None.
Authors: Wigdan H Farah; Mouaz Alsawas; Maria Mainou; Fares Alahdab; Magdoleen H Farah; Ahmed T Ahmed; Essa A Mohamed; Jehad Almasri; Michael R Gionfriddo; Ana Castaneda-Guarderas; Khaled Mohammed; Zhen Wang; Noor Asi; Craig N Sawchuk; Mark D Williams; Larry J Prokop; M Hassan Murad; Annie LeBlanc Journal: Evid Based Med Date: 2016-11-11
Authors: Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Rachel A Murphy; Anne B Newman; Douglas C Bauer; Tamara B Harris; Zhou Yang; William B Applegate; Stephen B Kritchevsky Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Haris Riaz; Safi U Khan; Hammad Rahman; Nishant P Shah; Edo Kaluski; A Michael Lincoff; Steven E Nissen Journal: Eur J Prev Cardiol Date: 2018-12-06 Impact factor: 7.804
Authors: Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage Journal: N Engl J Med Date: 2018-08-26 Impact factor: 91.245
Authors: Andrew Mente; Martin O'Donnell; Sumathy Rangarajan; Gilles Dagenais; Scott Lear; Matthew McQueen; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Wei Li; Yin Lu; Sun Yi; Lei Rensheng; Romaina Iqbal; Prem Mony; Rita Yusuf; Khalid Yusoff; Andrzej Szuba; Aytekin Oguz; Annika Rosengren; Ahmad Bahonar; Afzalhussein Yusufali; Aletta Elisabeth Schutte; Jephat Chifamba; Johannes F E Mann; Sonia S Anand; Koon Teo; S Yusuf Journal: Lancet Date: 2016-05-20 Impact factor: 79.321
Authors: Tai Lim Kim; Gwang Hun Jeong; Jae Won Yang; Keum Hwa Lee; Andreas Kronbichler; Hans J van der Vliet; Giuseppe Grosso; Fabio Galvano; Dagfinn Aune; Jong Yeob Kim; Nicola Veronese; Brendon Stubbs; Marco Solmi; Ai Koyanagi; Sung Hwi Hong; Elena Dragioti; Eunyoung Cho; Leandro F M de Rezende; Edward L Giovannucci; Jae Il Shin; Gabriele Gamerith Journal: Adv Nutr Date: 2020-11-16 Impact factor: 8.701
Authors: JoAnn E Manson; Shari S Bassuk; Nancy R Cook; I-Min Lee; Samia Mora; Christine M Albert; Julie E Buring Journal: Circ Res Date: 2020-01-02 Impact factor: 17.367
Authors: Keum Hwa Lee; Hyo Jin Seong; Gaeun Kim; Gwang Hun Jeong; Jong Yeob Kim; Hyunbong Park; Eunyoung Jung; Andreas Kronbichler; Michael Eisenhut; Brendon Stubbs; Marco Solmi; Ai Koyanagi; Sung Hwi Hong; Elena Dragioti; Leandro Fórnias Machado de Rezende; Louis Jacob; NaNa Keum; Hans J van der Vliet; Eunyoung Cho; Nicola Veronese; Giuseppe Grosso; Shuji Ogino; Mingyang Song; Joaquim Radua; Sun Jae Jung; Trevor Thompson; Sarah E Jackson; Lee Smith; Lin Yang; Hans Oh; Eun Kyoung Choi; Jae Il Shin; Edward L Giovannucci; Gabriele Gamerith Journal: Adv Nutr Date: 2020-09-01 Impact factor: 8.701